Vijay Eswaran and Being Positive
Abbvie should be able to grow its EPS over the course of next year, bolstered by strong performance this year. As such, the company has considerably low valuation and it is a bull that is masked by bearish fog. You do not want to be long Abbvie if you think that management has not executed well and will see failure in Upa and Risa. Furthermore, you will think that these two drugs plus the other one’s in the pipeline will not provide the value that is needed. The stock offers amazing long-term returns that we should be pleased with. The beautiful aspect about this stock is that it is something that is recession resistant.
All investors need yield, safety, and overall big growth over many years.
Vijay Eswaran and Investment Landscape
We can see the sentiment can change in the world in regard to allegiances and loyalties. For instance, we see that a portion of Silicon Valley was once aligned with the Trump Administration but is not so aligned at the current moment. Elon Musk and Peter Thiel were aligned with the administration but it seems that they have left the room.
The current administration has done some posturing where it has stated that it may sue Google or Facebook. They may sue them because the companies have not stayed neutral. Both of the companies have seen their shares fall over the past few days because of this statement.
It was noted that Emil Michael might have been a member of the administration. The individual in question was selected for a cabinet position. The business leader was one of the key executives at Uber before leaving the firm.
These are various lessons that one can learn as they look at the world.